control group:Conventional Western medical treatment
Sponsors
Gerontological Society of Sichuan Provincial, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, The Second Peoples Hospital of Hunan Province (Brain Hospital of Hunan Provincial), Fengxian District Traditional Chinese Medicine Hospital, Shanghai
Conditions
Chronic Obstructive Pulmonary DiseaseChronic kidney diseaseCoronary microvascular dysfunctionHepatic cirrhosis with thrombocytopeniacommunity-acquired pneumoniahip fracture in the elderly
Phase 4
Unknown Phase
Exploring the effects of Xiefei Ditan Decoction on the airway mucus hypersecretion in elderly patients with AECOPD based on the lung regulating the waterway
RecruitingITMCTR2025000494
Start: 2024-06-01Updated: 2025-04-07
Based on the theory of "Yang density leads to stability", this study explores the mechanism by which the Fushen Xiezhuo Formula regulates mitochondrial metabolic reprogramming through the PI3K-AKT pathway in the treatment of chronic kidney disease.
RecruitingITMCTR2025002171
Start: 2025-04-13Updated: 2025-11-17
An open-label randomized controlled trial of bloodletting at the liver point for the treatment of thrombocytopenia in liver cirrhosis
Active, not recruitingITMCTR2026000219
Start: 2026-02-01Updated: 2026-03-02
The effect of Taohong Siwu Decoction on the healing of hip fracture in the elderly by regulating VEGF / PI3K / Akt signaling pathway
Active, not recruitingITMCTR2026000630
Start: 2025-05-01Updated: 2026-03-30
Observation on the Efficacy of Feire II Formula Combined with Cupping Therapy in the Treatment of Phlegm-Heat Obstructing the Lung Type Pneumonia
Active, not recruitingITMCTR2026000662
Start: 2023-11-01Updated: 2026-03-30